UCANN is a biotech company with a foundation built in the medical cannabis industry. UCANN is partnering domestically-internationally with local businessmen, entrepreneurs, scientists, and government agencies for the purpose of cultivating medical grade cannabis based products worldwide.
This case addresses whether attorneys fees are warranted due to an inequitable conduct and conflict of interest defense. Background UCANN
In 2018, United Cannabis Corporation (“UCANN”) sued Pure Hemp Collective (“Pure Hemp”) for infringement of U.S. Patent No. 9,730,911 (the “‘911 patent”),
United Cannabis Corporation v. Pure Hemp Collective Inc., Docket No. 22-01363 (Fed. Cir. 2023) This case is still pending before the
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Cannabis Products Global Market Report 2023” – https://www.
Be the first to receive the latest buzz contests & more!